Trifecta-Kidney cfDNA-MMDx Study

Age: Not specified

Healthy Volunteers:

This study is NOT accepting healthy volunteers

Inclusion Criteria:

* All kidney transplant recipients undergoing a kidney biopsy for clinical indications, as determined by their physician or surgeon, will be eligible to enroll in the study.

Exclusion Criteria:

* Patients will be excluded from the study if they decline participation or are unable to give informed consent or multiple organ recipients.

Interventions:

DIAGNOSTIC_TEST: MMDx, DIAGNOSTIC_TEST: Prospera, DIAGNOSTIC_TEST: HLA antibody

Conditions:

Kidney Transplant Rejection

Keywords:

donor derived cell-free DNA, blood, kidney biopsy

Contact(s): Konrad S Famulski, PhD - konrad@ualberta.ca

Principal Investigator:

Phase:

IRB Number:

System ID: NCT04239703

See this study on ClinicalTrials.gov

Thank you for choosing StudyFinder. Please visit http://studyfinder.cctr.vcu.edu to find a Study which is right for you and contact ctrrecruit@vcu.edu if you have questions or need assistance.

Trifecta-Kidney cfDNA-MMDx Study

Email this study information to me

Contact the study team